Insight

New study on overdiagnosis of prostate cancer in Europe – IARC

Photo taken from IARC/LinkedIn

Sep 10, 2024, 01:15

New study on overdiagnosis of prostate cancer in Europe – IARC

IARC – International Agency for Research on Cancer shared the following on LinkedIn:

“A paper on overdiagnosis of prostate cancer in Europe focuses on epidemiological characteristics of prostate cancer in Europe, and contrasts between heterogeneous incidence trends and more uniform decreases in mortality from prostate cancer.

Study published in The BMJ.”

Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study

Authors: Salvatore Vaccarella, Mengmeng Li, Freddie Bray, Rune Kvale, Diego Serraino, Valentina Lorenzoni, Anssi Auvinen, Luigino Dal Maso

New study on overdiagnosis of prostate cancer in Europe - IARC

Read further.
Source: IARC – International Agency for Research on Cancer/LinkedIn

Anssi Auvinen cancer Diego Serraino epidemiology europe Freddie Bray IARC International Agency for Research on Cancer Luigino Dal Maso Mengmeng Li OncoDaily Oncology overdiagnosis prostate cancer Rune Kvale Salvatore Vaccarella The BMJ Valentina Lorenzoni

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage